Journal ArticleDOI
SwissParam: a fast force field generation tool for small organic molecules.
Reads0
Chats0
TLDR
A fast force field generation tool, called SwissParam, able to generate, for arbitrary small organic molecule, topologies, and parameters based on the Merck molecular force field, but in a functional form that is compatible with the CHARMM force field is presented.Abstract:
The drug discovery process has been deeply transformed recently by the use of computational ligand-based or structure-based methods, helping the lead compounds identification and optimization, and finally the delivery of new drug candidates more quickly and at lower cost. Structure-based computational methods for drug discovery mainly involve ligand-protein docking and rapid binding free energy estimation, both of which require force field parameterization for many drug candidates. Here, we present a fast force field generation tool, called SwissParam, able to generate, for arbitrary small organic molecule, topologies, and parameters based on the Merck molecular force field, but in a functional form that is compatible with the CHARMM force field. Output files can be used with CHARMM or GROMACS. The topologies and parameters generated by SwissParam are used by the docking software EADock2 and EADock DSS to describe the small molecules to be docked, whereas the protein is described by the CHARMM force field, and allow them to reach success rates ranging from 56 to 78%. We have also developed a rapid binding free energy estimation approach, using SwissParam for ligands and CHARMM22/27 for proteins, which requires only a short minimization to reproduce the experimental binding free energy of 214 ligand-protein complexes involving 62 different proteins, with a standard error of 2.0 kcal mol(-1), and a correlation coefficient of 0.74. Together, these results demonstrate the relevance of using SwissParam topologies and parameters to describe small organic molecules in computer-aided drug design applications, together with a CHARMM22/27 description of the target protein. SwissParam is available free of charge for academic users at www.swissparam.ch.read more
Citations
More filters
Journal ArticleDOI
Synthesis & characterization of heterocyclic disazo - azomethine dyes and investigating their molecular docking & dynamics properties on acetylcholine esterase (AChE), heat shock protein (HSP90α), nicotinamide N-methyl transferase (NNMT) and SARS-CoV-2 (2019-nCoV, COVID-19) main protease (Mpro)
TL;DR: In this article , the authors used 5-amino-4-arylazo-3-methyl-1H-pyrazole derivatives and 2-hydroxy-5-(phenyldiazenyl) benzaldehyde to synthesize heterocyclic disperse disazo-azomethine dyes.
Journal ArticleDOI
Insights into the structure and molecular topography of the fatty acylated domain of synaptotagmin-1.
TL;DR: The synthesized N-acetylated, C-end amidated and Cys-palmitated peptide which includes the fatty acylated cysteine residues in the membrane-affiliated domain of synaptotagmin-1 is suggested to adopt β-structure in biological membranes.
Journal ArticleDOI
Light-induced protein structural dynamics in bacteriophytochrome revealed by time-resolved x-ray solution scattering
Sang Jin Lee,Tae Wu Kim,Jong Goo Kim,Cheolhee Yang,So Ri Yun,Changin Kim,Zhong Ren,Indika Kumarapperuma,Jane Kuk,Keith Moffat,Xiaojing Yang,Hyotcherl Ihee +11 more
TL;DR: Mechanistic insights are provided into how modular signaling proteins such as BphPs transmit structural signals over long distances and regulate their downstream biological responses.
Journal ArticleDOI
Synthesis, biological evaluation, and modeling studies of 1,3-disubstituted cyclobutane-containing analogs of combretastatin A4.
Andrii Malashchuk,Anton V. Chernykh,Vasyl V. Hurmach,Vasyl V. Hurmach,M. O. Platonov,Oleksandra Onopchenko,Sergey Zozulya,Constantin G. Daniliuc,Alexey V. Dobrydnev,Alexey V. Dobrydnev,Ivan S. Kondratov,Yuriy S. Moroz,Oleksandr O. Grygorenko,Oleksandr O. Grygorenko +13 more
TL;DR: Novel CA4 analogs bearing 1,3-cyclobutane moiety instead of the cis-stilbene unit of the parent compound were designed, circumventing the adverse cis/trans-isomerization of combretastatin A4, a naturally occurring tumor-vascular disrupting agent.
References
More filters
Journal ArticleDOI
UCSF Chimera--a visualization system for exploratory research and analysis.
Eric F. Pettersen,Thomas D. Goddard,Conrad C. Huang,Gregory S. Couch,Daniel M. Greenblatt,Elaine C. Meng,Thomas E. Ferrin +6 more
TL;DR: Two unusual extensions are presented: Multiscale, which adds the ability to visualize large‐scale molecular assemblies such as viral coats, and Collaboratory, which allows researchers to share a Chimera session interactively despite being at separate locales.
Journal ArticleDOI
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
TL;DR: A new implementation of the molecular simulation toolkit GROMACS is presented which now both achieves extremely high performance on single processors from algorithmic optimizations and hand-coded routines and simultaneously scales very well on parallel machines.
Journal ArticleDOI
Development and testing of a general amber force field.
TL;DR: A general Amber force field for organic molecules is described, designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most organic and pharmaceutical molecules that are composed of H, C, N, O, S, P, and halogens.
Journal ArticleDOI
All-atom empirical potential for molecular modeling and dynamics studies of proteins.
Alexander D. MacKerell,D. Bashford,M. Bellott,Roland L. Dunbrack,Jeffrey D. Evanseck,Martin J. Field,Stefan Fischer,Jiali Gao,H. Guo,S. Ha,Diane Joseph-McCarthy,L. Kuchnir,K. Kuczera,F. T. K. Lau,C. Mattos,Stephen W. Michnick,Thien H. Ngo,D. T. Nguyen,B. Prodhom,W. E. Reiher,Benoît Roux,M. Schlenkrich,Jeremy C. Smith,Roland H. Stote,John E. Straub,Masakatsu Watanabe,J. Wiórkiewicz-Kuczera,D. Yin,Martin Karplus +28 more
TL;DR: The results demonstrate that use of ab initio structural and energetic data by themselves are not sufficient to obtain an adequate backbone representation for peptides and proteins in solution and in crystals.
Journal ArticleDOI
The Cambridge Structural Database: a quarter of a million crystal structures and rising
TL;DR: The Cambridge Structural Database now contains data for more than a quarter of a million small-molecule crystal structures, and projections concerning future accession rates indicate that the CSD will contain at least 500,000 crystal structures by the year 2010.